{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:40:47Z","timestamp":1790804447184,"version":"4.1.0"},"reference-count":67,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Polpharma Scientific Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Background and aims: Systemic sclerosis (SSc) is an autoimmune, rare multisystem chronic disease that is still not well-understood aetiologically and is challenging diagnostically. In the literature, there are ever-increasing assumptions regarding the epigenetic mechanisms involved in SSc development; one of them is circulating microRNAs. Many of them regulate TLR pathways and are significant in autoimmune balance. The aim of this study was to determine profile expression of selected microRNAs in SSc patients, including miR-126, -132, -143, -145, -155, -181a, -29a and -3148, in comparison to healthy controls. Methods: Serum microRNAs were isolated from 45 patients with SSc and 57 healthy donors (HC). Additionally, SSc patients were considered in the aspect of disease subtype, including diffuse systemic sclerosis (dcSSc) and limited systemic sclerosis (lcSSc). Results: miR-3148 was detected neither in the serum of HC nor in SSc patients. All of the rest of the analyzed microRNAs, excluding miR-126, miR-29a and miR-181a, were significantly upregulated in SSc patients in comparison to HC. However, miR-181a has been revealed only in the serum of patients with lcSSc but not dcSSc. Moderate positive correlations between the transfer factor of the lung for carbon monoxide (TLCO) and miR-126 and miR-145 were observed. A significant correlation has been found between serum miR-143 level and forced vital capacity (FVC). SSc patients with FVC \u2264 70% were characterized by significantly lower levels of miR-143 compared to patients with normal FVC. Additionally, the expression of miR-132 was significantly higher in dcSSc subgroup with detected active lung lesions compared to dcSSc patients with fibrotic lesions. Patients with an early scleroderma pattern of microangiopathy seen on nailfold video-capillaroscopy (NVC) revealed higher expression of miR-155 in serum than those with a late pattern. Conclusions: The expression profile of circulating cell-free miRNAs is significantly changed in the serum of SSc patients compared to healthy individuals. Downregulation of miRNA-181a and overexpression of miR-132, miR-143, miR-145 and miR-155 in serum may be significant in SSc in the context of biomarkers.<\/jats:p>","DOI":"10.3390\/ijms231810731","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T23:16:36Z","timestamp":1663197396000},"page":"10731","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Serum microRNAs in Systemic Sclerosis, Associations with Digital Vasculopathy and Lung Involvement"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6384-2916","authenticated-orcid":false,"given":"Anna","family":"Wajda","sequence":"first","affiliation":[{"name":"Department of Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1255-1830","authenticated-orcid":false,"given":"Marcela","family":"Walczyk","sequence":"additional","affiliation":[{"name":"Department of Connective Tissue Diseases, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Dudek","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Stypi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Lewandowska","sequence":"additional","affiliation":[{"name":"Department of Connective Tissue Diseases, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Romanowska-Pr\u00f3chnicka","sequence":"additional","affiliation":[{"name":"Department of General and Experimental Pathology with Centre for Preclinical Research and Technology (CEPT), Medical University of Warsaw, 02-097 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3156-0740","authenticated-orcid":false,"given":"Marek","family":"Chojnowski","sequence":"additional","affiliation":[{"name":"Department of Connective Tissue Diseases, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3028-1061","authenticated-orcid":false,"given":"Marzena","family":"Olesi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Connective Tissue Diseases, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4249-3136","authenticated-orcid":false,"given":"Agnieszka","family":"Paradowska-Gorycka","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","article-title":"Pathogenesis of systemic sclerosis","volume":"6","author":"Pattanaik","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/art.11173","article-title":"Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies","volume":"48","author":"Medsger","year":"2003","journal-title":"Arthritis Rheum."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"17300","DOI":"10.1038\/s41598-020-74179-6","article-title":"Dermal fibroblasts have different extracellular matrix profiles induced by TGF-\u03b2, PDGF and IL-6 in a model for skin fibrosis","volume":"10","author":"Juhl","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/1874312901206010103","article-title":"Regulation of Matrix Remodeling by Peroxisome Proliferator-Activated Receptor-\u03b3: A Novel Link Between Metabolism and Fibrogenesis","volume":"6","author":"Wei","year":"2012","journal-title":"Open Rheumatol. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"90579","DOI":"10.18632\/oncotarget.21234","article-title":"Interactions between TGF-\u03b21, canonical WNT\/\u03b2-catenin pathway and PPAR \u03b3 in radiation-induced fibrosis","volume":"8","author":"Lecarpentier","year":"2017","journal-title":"Oncotarget"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/ar596","article-title":"Angiogenic and angiostatic factors in systemic sclerosis: Increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers","volume":"4","author":"Distler","year":"2002","journal-title":"Arthritis Res."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Truchetet, M.E., Brembilla, N.C., and Chizzolini, C. (2021). Current Concepts on the Pathogenesis of Systemic Sclerosis. Clin. Rev. Allergy Immunol.","DOI":"10.1007\/s12016-021-08889-8"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.rdc.2007.12.004","article-title":"Vascular Disease in Scleroderma: Mechanisms of Vascular Injury","volume":"34","author":"Kahaleh","year":"2008","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_10","first-page":"3","article-title":"Role of viral infections in the etiopathogenesis of systemic sclerosis","volume":"2","author":"Moroncini","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/jid.2013.423","article-title":"Epstein-barr virus infection induces aberrant TLR activation pathway and fibroblast-myofibroblast conversion in Scleroderma","volume":"134","author":"Farina","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.15171\/apb.2015.082","article-title":"Toll-like receptors in the pathogenesis of autoimmune diseases","volume":"5","author":"Hosseini","year":"2015","journal-title":"Adv. Pharm. Bull."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Gilad, S., Meiri, E., Yogev, Y., Benjamin, S., Lebanony, D., Yerushalmi, N., Benjamin, H., Kushnir, M., Cholakh, H., and Melamed, N. (2008). Serum microRNAs are promising novel biomarkers. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0003148"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"8265","DOI":"10.1038\/s41598-019-44580-x","article-title":"A comparative characterization of the circulating miRNome in whole blood and serum of HCC patients","volume":"9","author":"Pascut","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Stypinska, B., Wajda, A., Walczuk, E., Olesinska, M., Lewandowska, A., Walczyk, M., and Paradowska-Gorycka, A. (2020). The Serum Cell-Free microRNA Expression Profile in MCTD, SLE, SSc, and RA Patients. J. Clin. Med., 9.","DOI":"10.3390\/jcm9010161"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jaut.2017.12.015","article-title":"Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis","volume":"89","author":"Chouri","year":"2018","journal-title":"J. Autoimmun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3899\/jrheum.140502","article-title":"The circulating cell-free microRNA profile in systemic sclerosis is distinct from both healthy controls and systemic lupus erythematosus","volume":"42","author":"Steen","year":"2015","journal-title":"J. Rheumatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.21037\/atm-21-4342","article-title":"The expression profiling of microRNA in systemic sclerosis-associated pulmonary arterial hypertension","volume":"9","author":"Huang","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/1756-185X.13924","article-title":"Meta-analysis of differentially expressed microRNAs in systemic sclerosis","volume":"23","author":"Zhang","year":"2020","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/art.27443","article-title":"MicroRNA-29, a key regulator of collagen expression in systemic sclerosis","volume":"62","author":"Maurer","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1093\/rheumatology\/kev234","article-title":"Specific autoantibody profiles and disease subgroups correlate with circulating micro-RNA in systemic sclerosis","volume":"54","author":"Wuttge","year":"2015","journal-title":"Rheumatology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.autrev.2009.02.018","article-title":"Anti-topoisomerase I autoantibodies in systemic sclerosis","volume":"8","author":"Simon","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1186\/s13071-021-05063-z","article-title":"miR-181a regulates the host immune response against Schistosoma japonicum infection through the TLR4 receptor pathway","volume":"14","author":"Tang","year":"2021","journal-title":"Parasites Vectors"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Xie, W., Li, M., Xu, N., Lv, Q., Huang, N., He, J., and Zhang, Y. (2013). miR-181a Regulates Inflammation Responses in Monocytes and Macrophages. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0058639"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/art.37890","article-title":"Circulating microRNA expression profiles associated with systemic lupus erythematosus","volume":"65","author":"Carlsen","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_27","first-page":"4790","article-title":"Expression and clinical significance of miR-181a and miR-203 in systemic lupus erythematosus patients","volume":"21","author":"Li","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: An American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"Khanna","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"ref_29","first-page":"155","article-title":"Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis","volume":"27","author":"Cutolo","year":"2000","journal-title":"J. Rheumatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2012.12.009","article-title":"Regulation of the MIR155 host gene in physiological and pathological processes","volume":"532","author":"Elton","year":"2013","journal-title":"Gene"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Eissa, M.G., and Artlett, C.M. (2019). The microRNA miR-155 is essential in fibrosis. Non-Coding RNA, 5.","DOI":"10.3390\/ncrna5010023"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13075-016-1054-6","article-title":"miR-155 in the progression of lung fibrosis in systemic sclerosis","volume":"18","author":"Christmann","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13075-017-1331-z","article-title":"Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis","volume":"19","author":"Artlett","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1161\/CIRCULATIONAHA.114.014579","article-title":"MicroRNA-155 Exerts Cell-Specific Antiangiogenic but Proarteriogenic Effects During Adaptive Neovascularization","volume":"131","author":"Pankratz","year":"2015","journal-title":"Circulation"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.immuni.2007.10.009","article-title":"microRNA-155 Regulates the Generation of Immunoglobulin Class-Switched Plasma Cells","volume":"27","author":"Vigorito","year":"2007","journal-title":"Immunity"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1126\/science.1139253","article-title":"Requirement of bic\/microRNA-155 for normal immune function","volume":"316","author":"Rodriguez","year":"2007","journal-title":"Science"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): A randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Le Gouellec, N., Duhamel, A., Perez, T., Hachulla, A.L., Sobanski, V., Faivre, J.B., Morell-Dubois, S., Lambert, M., Hatron, P.Y., and Hachulla, E. (2017). Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0181692"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Jordan, N.P., Tingle, S.J., Shuttleworth, V.G., Cooke, K., Redgrave, R.E., Singh, E., Glover, E.K., Ahmad Tajuddin, H.B., Kirby, J.A., and Arthur, H.M. (2021). Mir-126-3p is dynamically regulated in endothelial-to-mesenchymal transition during fibrosis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168629"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.20517\/2347-8659.2018.01","article-title":"MicroRNA-126 is a prospective target for vascular disease","volume":"5","author":"Qu","year":"2018","journal-title":"Neuroimmunol. Neuroinflammation"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1038\/s41598-019-39485-8","article-title":"Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts","volume":"9","author":"Liakouli","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s10875-011-9647-y","article-title":"MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma","volume":"32","author":"Zhu","year":"2012","journal-title":"J. Clin. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.bbrc.2019.12.120","article-title":"microRNA-145 mediates xylosyltransferase-I induction in myofibroblasts via suppression of transcription factor KLF4","volume":"523","author":"Ly","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/annrheumdis-2021-221050","article-title":"Antifibrotic factor KLF4 is repressed by the miR-10\/TFAP2A\/TBX5 axis in dermal fibroblasts: Insights from twins discordant for systemic sclerosis","volume":"81","author":"Malaab","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"40468","DOI":"10.1038\/srep40468","article-title":"MircoRNA-145 promotes activation of hepatic stellate cells via targeting kr\u00fcppel-like factor 4","volume":"7","author":"Men","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3892\/ijmm.2015.2189","article-title":"Epigenetic repression of Kr\u00fcppel-like factor 4 through Dnmt1 contributes to EMT in renal fibrosis","volume":"35","author":"Xiao","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Dubitzky, W., Wolkenhauer, O., Cho, K.-H., and Yokota, H. (2013). MicroRNA Clusters. Encyclopedia of Systems Biology, Springer.","DOI":"10.1007\/978-1-4419-9863-7"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1101\/gad.1842409","article-title":"MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury","volume":"23","author":"Xin","year":"2009","journal-title":"Genes Dev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/jcmm.14750","article-title":"microRNA-143-3p attenuated development of hepatic fibrosis in autoimmune hepatitis through regulation of TAK1 phosphorylation","volume":"24","author":"Tu","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e15295","DOI":"10.15252\/emmm.202115295","article-title":"Blockade of the pro-fibrotic reaction mediated by the miR-143\/-145 cluster enhances the responses to targeted therapy in melanoma","volume":"14","author":"Diazzi","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"ref_51","first-page":"12738","article-title":"miR-143 down-regulates TLR2 expression in hepatoma cells and inhibits hepatoma cell proliferation and invasion","volume":"8","author":"Liu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3389\/fimmu.2019.01475","article-title":"Plasma MicroRNAs in Established Rheumatoid Arthritis Relate to Adiposity and Altered Plasma and Skeletal Muscle Cytokine and Metabolic Profiles","volume":"10","author":"Andonian","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_53","first-page":"166","article-title":"Silencing of LncRNA TCONS_00088786 reduces renal fibrosis through miR-132","volume":"22","author":"Zhou","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"BSR20201696","DOI":"10.1042\/BSR20201696","article-title":"MicroRNA-132 attenuated cardiac fibrosis in myocardial infarction-induced heart failure rats","volume":"40","author":"Wang","year":"2020","journal-title":"Biosci. Rep."},{"key":"ref_55","first-page":"178","article-title":"Novel antisense therapy targeting microRNA-132 in patients with heart failure: Results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study","volume":"42","author":"Hauke","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.omtn.2021.05.007","article-title":"Protective effect of LNA-anti-miR-132 therapy on liver fibrosis in mice","volume":"25","author":"Catalano","year":"2021","journal-title":"Mol. Ther.-Nucleic Acids"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/rheumatology\/key327","article-title":"Methyl cap binding protein 2: A key epigenetic protein in systemic sclerosis","volume":"58","author":"Henderson","year":"2019","journal-title":"Rheumatology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1111\/bph.14679","article-title":"Amlodipine induces vasodilation via Akt2\/Sp1-activated miR-21 in smooth muscle cells","volume":"176","author":"Fang","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"108799","DOI":"10.1016\/j.biopha.2019.108799","article-title":"S-amlodipine improves endothelial dysfunction via the RANK\/RANKL\/OPG system by regulating microRNA-155 in hypertension","volume":"114","author":"Yang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_60","unstructured":"(2022, September 09). Chiral Drugs\u2013S-Amlodipine, Calcium Channel Blocker. Available online: http:\/\/www.chiralemcure.com\/pop\/S-amlodipine_globalpresence.html."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"8681792","DOI":"10.1155\/2018\/8681792","article-title":"S-Amlodipine: An Isomer with Difference-Time to Shift from Racemic Amlodipine","volume":"2018","author":"Dalal","year":"2018","journal-title":"Int. J. Hypertens."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Iwamoto, N., Furukawa, K., Endo, Y., Shimizu, T., Sumiyoshi, R., Umeda, M., Koga, T., Kawashiri, S.Y., Igawa, T., and Ichinose, K. (2021). Methotrexate alters the expression of microrna in fibroblast-like synovial cells in rheumatoid arthritis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111561"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e58064","DOI":"10.7554\/eLife.58064","article-title":"Methotrexate attenuates vascular inflammation through an adenosine-microRNA-dependent pathway","volume":"10","author":"Yang","year":"2021","journal-title":"Elife"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fgene.2013.00083","article-title":"Comparison of methods for miRNA extraction from plasma and quantitative recovery of RNA from cerebrospinal fluid","volume":"4","author":"McAlexander","year":"2013","journal-title":"Front. Genet."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"bpz006","DOI":"10.1093\/biomethods\/bpz006","article-title":"Plasma or serum? A qualitative study on rodents and humans using high-throughput microRNA sequencing for circulating biomarkers","volume":"4","author":"Dufourd","year":"2019","journal-title":"Biol. Methods Protoc."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"102458","DOI":"10.1016\/j.autrev.2020.102458","article-title":"Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud\u2019s phenomenon and systemic sclerosis","volume":"19","author":"Smith","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_67","first-page":"378","article-title":"Differentiation of linear and reticular opacities in high resolution computed tomography (HRCT) in interstitial lung diseases","volume":"58","author":"Kurys","year":"2003","journal-title":"Ann. Univ. Mariae Curie-Sk\u0142odowska. Sect. D Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/18\/10731\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:31:38Z","timestamp":1760142698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/18\/10731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,14]]},"references-count":67,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["ijms231810731"],"URL":"https:\/\/doi.org\/10.3390\/ijms231810731","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,14]]}}}